Decrease in Fracture Rate with Mandatory Bone-protecting Agents in the EORTC 1333/PEACE-3 Trial Comparing Radium-223 Combined with Enzalutamide Versus Enzalutamide Alone: A Safety Analysis

Gillessen, Silke; Tombal, Bertrand; Turco, Fabio; Choudhury, Ananya; Rodriguez-Vida, Alejo; Gallardo, Enrique; Velho, Pedro Isaacsson; Nolè, Franco; Cruz, Felipe; Loriot, Yohann; McDermott, Ray; Roumeguere, Thierry; Daugaard, Gedske; Yamamura, Rosley; Bompas, Emmanuelle; Maroto, Pablo; Polo, Manuel Herrero; da Trindade, Karine Martins; Preto, Daniel D’Almeida; Skoneczna, Iwona

doi:10.1016/j.eururo.2024.11.027

Decrease in Fracture Rate with Mandatory Bone-protecting Agents in the EORTC 1333/PEACE-3 Trial Comparing Radium-223 Combined with Enzalutamide Versus Enzalutamide Alone: A Safety Analysis

Gillessen, Silke

;

Tombal, Bertrand

;

Turco, Fabio

;

Choudhury, Ananya

;

Saad, Fred

;et.al.

(2025) European Urology — Vol. 87, n° 3, p. 285-288 (2025)

Files

Gillessen_Fractures39827019.pdf

Open Access
Adobe PDF
533.7 KB

Download

Details

Authors

Gillessen, Silke
Author
Tombal, BertrandUCLouvain
Author
Turco, Fabio
Author
Choudhury, Ananya
Author
Lecouvet, FredericUCLouvain
Author
Saad, Fred
Author

Affiliations

UCLouvainSSS/IREC/CHEX - Pôle de chirgurgie expérimentale et transplantation

Citations

APA
Chicago
FWB

Gillessen, S., Tombal, B., Turco, F., Choudhury, A., Rodriguez-Vida, A., Gallardo, E., Velho, P. I., Nolè, F., Cruz, F., Loriot, Y., McDermott, R., Roumeguere, T., Daugaard, G., Yamamura, R., Bompas, E., Maroto, P., Polo, M. H., da Trindade, K. M., Preto, D. D., et al. (2025). Decrease in Fracture Rate with Mandatory Bone-protecting Agents in the EORTC 1333/PEACE-3 Trial Comparing Radium-223 Combined with Enzalutamide Versus Enzalutamide Alone: A Safety Analysis. European Urology, 87(3), 285-288. https://doi.org/10.1016/j.eururo.2024.11.027 (Original work published 2025)